3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
161
Squamous Cell Carcinoma of Head and Neck
95
Head and Neck Neoplasms
95
Colonic Neoplasms
46
Rectal Neoplasms
39
Neoplasm Metastasis
35
Carcinoma, Non-Small-Cell Lung
29
Carcinoma, Squamous Cell
25
Pancreatic Neoplasms
18
Neoplasms
18
Esophageal Neoplasms
18
Lung Neoplasms
17
Stomach Neoplasms
13
Laryngeal Neoplasms
12
Recurrence
11
Oropharyngeal Neoplasms
11
Mouth Neoplasms
11
Esophageal Squamous Cell Carcinoma
11
Colorectal Cancer Metastatic
10
Tongue Neoplasms
9
Carcinoma
9
Breast Neoplasms
9
Nasopharyngeal Carcinoma
8
Hypopharyngeal Neoplasms
8
Adenocarcinoma Of Esophagus
8
Laryngeal Diseases
6
Salivary Gland Neoplasms
5
Neoplasms, Squamous Cell
5
Glioblastoma
5
Uterine Cervical Neoplasms
4
Interventions
Gemcitabine
58
Cisplatin
41
Capecitabine
27
Oxaliplatin
25
durvalumab
16
Fluorouracil
16
Leucovorin
15
S 1 (combination)
11
lenvatinib
10
Nivolumab
10
Irinotecan
10
pembrolizumab
8
apatinib
8
Immune Checkpoint Inhibitors
7
130-nm albumin-bound paclitaxel
7
tremelimumab
6
Bevacizumab
6
camrelizumab
5
Trastuzumab
5
Drug Therapy
5
Blood Specimen Collection
5
Albumin-Bound Paclitaxel
5
tislelizumab
4
irinotecan sucrosofate
4
Taxes
4
Liquid Biopsy
4
Folfox protocol
4
toripalimab
3
surufatinib
3
gemcitabine-oxaliplatin regimen
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Biliary Tract Neoplasms
×
Cetuximab
×
Clear all
NCT01267344
2016-05-04
BTC
National Health Research Institutes, Taiwan
Phase 2
Completed
122 enrolled